4
Changes in Ownership
ALX ONCOLOGY HOLDINGS INC Filed Acc 0001209191-21-056787
Chief Financial Officer sold 12,771 shares at an average $79.13 ($1,010,506)
- Chief Financial Officer acquired 12,771 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
GARCIA PETER S · Chief Financial Officer
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-16 | Exercise or conversion : show line 1 in the form | +1,426 | $4.08 | $5,818 | 10,757 | D |
| 2021-09-16 | Sale : show line 2 in the form | −1,426 | $80.43 | $114,695 | 9,331 | D |
| 2021-09-17 | Exercise or conversion : show line 3 in the form | +11,345 | $4.08 | $46,288 | 20,676 | D |
| 2021-09-17 | Sale : show line 4 in the form | −1,027 | $77.84 | $79,944 | 19,649 | D |
| 2021-09-17 | Sale : show line 5 in the form | −7,199 | $78.61 | $565,922 | 12,450 | D |
| 2021-09-17 | Sale : show line 6 in the form | −1,746 | $79.46 | $138,734 | 10,704 | D |
| 2021-09-17 | Sale : show line 7 in the form | −273 | $80.22 | $21,901 | 10,431 | D |
| 2021-09-17 | Sale : show line 8 in the form | −1,100 | $81.19 | $89,309 | 9,331 | D |
| Open-market sales · 12,771 sh · avg $79.13 · $1,010,506 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-09-16 | Exercise or conversion : show line 9 in the form Employee Stock Option (right to buy) | −1,426 | 79,042 | D |
| 2021-09-17 | Exercise or conversion : show line 10 in the form Employee Stock Option (right to buy) | −11,345 | 67,697 | D |
Loading xslF345X03/doc4.xml…